The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global PRF Treatment Market Research Report 2025

Global PRF Treatment Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1737832

No of Pages : 86

Synopsis
PRF treatment, also known as Platelet-Rich Fibrin treatment, is a regenerative medical procedure that utilizes a patient's own blood to promote healing and tissue regeneration. It involves the extraction and processing of blood to concentrate the platelets and growth factors, which are then injected or applied topically to the area requiring treatment. PRF treatment is commonly used in various medical fields, including orthopedics, dentistry, dermatology, and plastic surgery, to accelerate healing, reduce inflammation, and enhance tissue regeneration. It is a minimally invasive and natural approach that can aid in the recovery process for certain injuries, wounds, and skin conditions.
Global PRF Treatment market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole PRF Treatment market research.
The PRF (Platelet-Rich Fibrin) treatment market is a growing sector in the medical and cosmetic industries. PRF is a natural and autologous (derived from the patient's own blood) therapy that utilizes platelets and growth factors to stimulate tissue healing and regeneration. It has applications in various fields, including orthopedics, dentistry, dermatology, and plastic surgery.
The PRF treatment market has witnessed significant growth in recent years due to its effectiveness, minimal side effects, and increasing demand for non-surgical and minimally invasive procedures. The market is driven by factors such as the rising prevalence of chronic diseases, sports injuries, dental disorders, and aesthetic concerns.
Key players in the PRF treatment market include medical device manufacturers, pharmaceutical companies, and clinics offering PRF therapies. These companies develop and market PRF preparation kits, centrifuges, and related equipment.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global PRF Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
HB Health
Grifols International S.A.
Kedrion S.p.A.
LFB
Bio Products Laboratory Ltd
China Biologic Products, Inc.
Octapharma
BioLife Plasma Services
Cambryn Biologics LLC
Biotest
CSL Ltd.
Santa Maria
Segment by Type
Autologous
Allogenic
Segment by Application
Plastic Surgery
Orthopedics
Dermatology
Androgenic Alopecia
Dental
Cardiac Muscle Injury
Nerve Injury
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The PRF Treatment report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global PRF Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Autologous
1.2.3 Allogenic
1.3 Market by Application
1.3.1 Global PRF Treatment Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Plastic Surgery
1.3.3 Orthopedics
1.3.4 Dermatology
1.3.5 Androgenic Alopecia
1.3.6 Dental
1.3.7 Cardiac Muscle Injury
1.3.8 Nerve Injury
1.3.9 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global PRF Treatment Market Perspective (2018-2029)
2.2 PRF Treatment Growth Trends by Region
2.2.1 Global PRF Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 PRF Treatment Historic Market Size by Region (2018-2023)
2.2.3 PRF Treatment Forecasted Market Size by Region (2024-2029)
2.3 PRF Treatment Market Dynamics
2.3.1 PRF Treatment Industry Trends
2.3.2 PRF Treatment Market Drivers
2.3.3 PRF Treatment Market Challenges
2.3.4 PRF Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top PRF Treatment Players by Revenue
3.1.1 Global Top PRF Treatment Players by Revenue (2018-2023)
3.1.2 Global PRF Treatment Revenue Market Share by Players (2018-2023)
3.2 Global PRF Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by PRF Treatment Revenue
3.4 Global PRF Treatment Market Concentration Ratio
3.4.1 Global PRF Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by PRF Treatment Revenue in 2022
3.5 PRF Treatment Key Players Head office and Area Served
3.6 Key Players PRF Treatment Product Solution and Service
3.7 Date of Enter into PRF Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 PRF Treatment Breakdown Data by Type
4.1 Global PRF Treatment Historic Market Size by Type (2018-2023)
4.2 Global PRF Treatment Forecasted Market Size by Type (2024-2029)
5 PRF Treatment Breakdown Data by Application
5.1 Global PRF Treatment Historic Market Size by Application (2018-2023)
5.2 Global PRF Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America PRF Treatment Market Size (2018-2029)
6.2 North America PRF Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America PRF Treatment Market Size by Country (2018-2023)
6.4 North America PRF Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe PRF Treatment Market Size (2018-2029)
7.2 Europe PRF Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe PRF Treatment Market Size by Country (2018-2023)
7.4 Europe PRF Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific PRF Treatment Market Size (2018-2029)
8.2 Asia-Pacific PRF Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific PRF Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific PRF Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America PRF Treatment Market Size (2018-2029)
9.2 Latin America PRF Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America PRF Treatment Market Size by Country (2018-2023)
9.4 Latin America PRF Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa PRF Treatment Market Size (2018-2029)
10.2 Middle East & Africa PRF Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa PRF Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa PRF Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 HB Health
11.1.1 HB Health Company Detail
11.1.2 HB Health Business Overview
11.1.3 HB Health PRF Treatment Introduction
11.1.4 HB Health Revenue in PRF Treatment Business (2018-2023)
11.1.5 HB Health Recent Development
11.2 Grifols International S.A.
11.2.1 Grifols International S.A. Company Detail
11.2.2 Grifols International S.A. Business Overview
11.2.3 Grifols International S.A. PRF Treatment Introduction
11.2.4 Grifols International S.A. Revenue in PRF Treatment Business (2018-2023)
11.2.5 Grifols International S.A. Recent Development
11.3 Kedrion S.p.A.
11.3.1 Kedrion S.p.A. Company Detail
11.3.2 Kedrion S.p.A. Business Overview
11.3.3 Kedrion S.p.A. PRF Treatment Introduction
11.3.4 Kedrion S.p.A. Revenue in PRF Treatment Business (2018-2023)
11.3.5 Kedrion S.p.A. Recent Development
11.4 LFB
11.4.1 LFB Company Detail
11.4.2 LFB Business Overview
11.4.3 LFB PRF Treatment Introduction
11.4.4 LFB Revenue in PRF Treatment Business (2018-2023)
11.4.5 LFB Recent Development
11.5 Bio Products Laboratory Ltd
11.5.1 Bio Products Laboratory Ltd Company Detail
11.5.2 Bio Products Laboratory Ltd Business Overview
11.5.3 Bio Products Laboratory Ltd PRF Treatment Introduction
11.5.4 Bio Products Laboratory Ltd Revenue in PRF Treatment Business (2018-2023)
11.5.5 Bio Products Laboratory Ltd Recent Development
11.6 China Biologic Products, Inc.
11.6.1 China Biologic Products, Inc. Company Detail
11.6.2 China Biologic Products, Inc. Business Overview
11.6.3 China Biologic Products, Inc. PRF Treatment Introduction
11.6.4 China Biologic Products, Inc. Revenue in PRF Treatment Business (2018-2023)
11.6.5 China Biologic Products, Inc. Recent Development
11.7 Octapharma
11.7.1 Octapharma Company Detail
11.7.2 Octapharma Business Overview
11.7.3 Octapharma PRF Treatment Introduction
11.7.4 Octapharma Revenue in PRF Treatment Business (2018-2023)
11.7.5 Octapharma Recent Development
11.8 BioLife Plasma Services
11.8.1 BioLife Plasma Services Company Detail
11.8.2 BioLife Plasma Services Business Overview
11.8.3 BioLife Plasma Services PRF Treatment Introduction
11.8.4 BioLife Plasma Services Revenue in PRF Treatment Business (2018-2023)
11.8.5 BioLife Plasma Services Recent Development
11.9 Cambryn Biologics LLC
11.9.1 Cambryn Biologics LLC Company Detail
11.9.2 Cambryn Biologics LLC Business Overview
11.9.3 Cambryn Biologics LLC PRF Treatment Introduction
11.9.4 Cambryn Biologics LLC Revenue in PRF Treatment Business (2018-2023)
11.9.5 Cambryn Biologics LLC Recent Development
11.10 Biotest
11.10.1 Biotest Company Detail
11.10.2 Biotest Business Overview
11.10.3 Biotest PRF Treatment Introduction
11.10.4 Biotest Revenue in PRF Treatment Business (2018-2023)
11.10.5 Biotest Recent Development
11.11 CSL Ltd.
11.11.1 CSL Ltd. Company Detail
11.11.2 CSL Ltd. Business Overview
11.11.3 CSL Ltd. PRF Treatment Introduction
11.11.4 CSL Ltd. Revenue in PRF Treatment Business (2018-2023)
11.11.5 CSL Ltd. Recent Development
11.12 Santa Maria
11.12.1 Santa Maria Company Detail
11.12.2 Santa Maria Business Overview
11.12.3 Santa Maria PRF Treatment Introduction
11.12.4 Santa Maria Revenue in PRF Treatment Business (2018-2023)
11.12.5 Santa Maria Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’